The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study

Completed

• Conditions: Thyroid Disease
• Interventions: Procedure: Thyroidectomy

• Registration Number: NCT04635813
• Lead Sponsor: University of Cagliari

Brief Summary

Italy has been on the frontline of the COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, the need to focus resources to deal with the pandemic led to a disruption of routine surgical care, as well as activity for oncologic and chronic disease. The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-10
• Primary Completion: 2020-09-30
• Status Verified: 2020-11
• Study Completion: 2020-11-12
• Study First Submitted: 2020-11-17
• Study First Submitted QC: 2020-11-18
• Last Update Submitted: 2020-11-18
• Study First Posted: 2020-11-19
• Last Update Posted: 2020-11-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3800

Inclusion Criteria

• patients that had undergone thyroidectomy during COVID-19 pandemic (from the 9th March to the 31st August 2020), defined as case group, or during the same period of the previous year (from the 9th Match to the 31st August 2019), defined as control group.

Exclusion Criteria

• incomplete data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Group 2 - control group	Thyroidectomy	Patients that underwent surgery during 2019
Group 1 - COVID group	Thyroidectomy	Patients that underwent surgery during COVID-19 pandemic

Primary Outcome Measures

Name	Time	Method
Quantify the overall reduction of surgical activity for thyroid disease	1 year

Secondary Outcome Measures

Name	Time	Method
Quantify the number of aggressive tumors operated during COVID-19 pandemic and the same period of the previous year	1 year	Comparison between the number of patients operated during COVID-19 pandemic with aggressive thyroid carcinoma (with lymph node metastasis, and/or extrathyroidal extension, and/or multifocality) with patients with aggressive thyroid carcinoma operated during the same period of the previous year
Quantify if the number of thyroid cancers operated during COVID-19 pandemic was significant different from the number of patients operated during the same period of the previous year	1 year

Trial Locations

Locations (1)

AOU Cagliari; 🇮🇹 Cagliari, CA, Italy